Sort
46,585 grants matching “heart failure”
Functional Analysis of the Cardiac Transcription Factor Nkx2.5
$572,654Children'S Hospital Boston · P50 · FY2005 · HL
Responses of Myocardial Ischemia to Sertraline Treatment
$572,589Wei Jiang · Duke University · R01 · FY2007 · HL
EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTION
$572,564Michael Regnier · University Of Washington · R01 · FY2014 · HL
Leveraging zebrafish models to dissect and enhance heart regeneration
$572,524Kenneth D Poss · Duke University · R35 · FY2024 · HL
STK25 phosphorylates PRKAR1A to regulate PKA signaling
$572,503Barry M. Fine · Columbia University Health Sciences · R01 · FY2025 · HL
P-ICECAP Extended
$572,494Stacy Jennifer Marcus Suskauer · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2025 · NS
Cardiac Myosin-Binding Protein C: Molecular Mechanisms Governing Cardiac Contractility
$572,444David M Warshaw · University Of Vermont & St Agric College · R01 · FY2020 · HL
Evaluating the natural evolution of myocardial stiffness in aging, sex differences, and through menopause transition in women, using a free-breathing magnetic resonance elastography approach
$572,414Arvin Forghanian-Arani · Mayo Clinic Rochester · R01 · FY2024 · HL
hiPSC Modeling of Restrictive Cardiomyopathy for Drug Testing
$572,391Mark Mercola · Stanford University · R01 · FY2023 · HL
CORE--GENOMICS AND GENOTYPING
$572,343Kathleen C Barnes · Johns Hopkins University · P50 · FY2010 · HL
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
$572,309Masako Morishita · Michigan State University · R01 · FY2020 · NR
Mediterranean diet, Metabolites, and Cardiovascular Disease
$572,249Frank B Hu · Harvard School Of Public Health · R01 · FY2022 · HL
Roles of SLC26A6 in Renal NaCI Transport and Prevention of Oxalate Urolithiasis
$572,226Peter S Aronson · Yale University · R37 · FY2010 · DK
Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP)
$572,149Mark J Siedner · Kwazulu-Natal Research Institute Tb-Hiv · R01 · FY2024 · HL
BDNF TrkB- and beta-AR signals in ischemic and non-ischemic cardiomyopathy
$572,100Nazareno Paolocci · Johns Hopkins University · R01 · FY2021 · HL
Role of Negative Elongation Factor Complex in RNA polymerase II pausing and gene transcription in Heart
$572,097Danish Sayed · Rutgers Biomedical And Health Sciences · R01 · FY2024 · HL
Blockade of S1P pathway for renal fibrosis therapy
$572,063Webster L Santos · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · DK
Training in Signature Transdisciplinary Cardiovascular Sciences
$571,962Mary G Sorci-Thomas · Medical College Of Wisconsin · T32 · FY2025 · HL
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B
$571,947Lynne E Wagenknecht · Wake Forest University Health Sciences · N01 · FY2025 · HL
Readily Available Biological Conduits to Treat Single Ventricle Defects
$571,889Yibing Qyang · Yale University · R01 · FY2024 · HL
Role of miR193 in oxidized lipid induced pulmonary hypertension
$571,850Mansoureh Eghbali · University Of California Los Angeles · R01 · FY2017 · HL
Role of miR193 in oxidized lipid induced pulmonary hypertension
$571,850Mansoureh Eghbali · University Of California Los Angeles · R01 · FY2019 · HL
Role of miR193 in oxidized lipid induced pulmonary hypertension
$571,850Mansoureh Eghbali · University Of California Los Angeles · R01 · FY2016 · HL
Role of miR193 in oxidized lipid induced pulmonary hypertension
$571,850Mansoureh Eghbali · University Of California Los Angeles · R01 · FY2018 · HL
hiPSC Modeling of Restrictive Cardiomyopathy for Drug Testing
$571,836Mark Mercola · Stanford University · R01 · FY2025 · HL